Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Nasal Tramazoline and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Tramazoline and (NTD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ioannis Koutsourelakis, University of Athens
ClinicalTrials.gov Identifier:
NCT01601509
First received: March 4, 2012
Last updated: May 17, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
No publications provided by University of Athens

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):